Followers | 6 |
Posts | 209 |
Boards Moderated | 0 |
Alias Born | 04/18/2020 |
Tuesday, February 02, 2021 6:29:21 PM
Cokadoodledue 4 hours ago
Here is my response to someone. It deserves it's own post.
@FactChecker, why should I convince you to do anything? I've done MY DD!! As far as NP is concerned, I've always supported him. Some, may not like his personality, his accent or some may have just had chips on their shoulders because things didn't happen as fast as they had wanted them to. As far as I'm concerned, for what he had to deal with, he has shined brightly!! I stood by him 100%. I continue to do so. And, as long as he keeps performing, I will always support him 100%.
As an aside, don't let disgruntled former employees, who felt that they should run the Company be your source of information. These folks can see a speck on NP's nose, but they can't see their own issues. If they didn't want to deal with him they didn't have to sell a Company to him, or choose to consult for him or whatever. He has had the FDA acting very unprofessional, in its bias against small Biotech. Remember the whole BP controversy this past year? Their studies getting done with mods. Only to authorize drugs, which were harmful, at worst, or didn't work, at best. (Remdesivir, RGEN's & LLY's mAbs, Hydrochloroquine, Convalescent Plasma). Everyone knew about Leronlimab's efficacy back in April. Yet, the only way NP could've gotten the drug quickly to the market would've resulted in partnering with BP, at a severe loss to future growth for shareholders.
Oh, and then there was the dilution. Hmm, well, first the were shorts depressing the price because of the way the FDA stuck it to the little guy. Then, you had the widow of the ex-CEO who had to be bought out (at a time when the stock price was really depressed). And, because the shorts continued to hamper efforts to raise capital at higher prices, NP was forced to dilute more. Shall I continue?
Okay, the NASDAQ. Let's see, you had all of these things happening, and then you had the former employees, mentioned above, decide to litigate against NP and its Officers. Talk about kicking someone when their down. But, it gets more complicated, perhaps by design, by those suing NP. You see, the NASDAQ doesn't like to see litigation. They also don't like to see the use of poison pills being employed. Then, of course, there's the shareholders equity. Well, you've got to appreciate the 'perfect storm', which was being orchestrated AGAINST NP. Can you see the negative synergy developing here? It's not like he was just dealing with these problems on their own. Their additive effects combined to create far greater problems for NP than the sum of their parts.
Oh, the poison pill. What is that, do you ask? The performance shares and convertibles awarded to management, which everyone was so upset over. They were 'awarded' to management in an effort to protect shareholders from a company like GILD from making a hostile takeover bid for pennies on the dollar.
But, you see, Covid came into the picture and changed EVERYTHING. Regardless of who claimed the credit for noticing Leronlimab's utility against Covid-19, it's immaterial!! Why? Because, NP still had all of those headwinds pushing against his forward progress. Despite everything, he was able to marshal the forces, and get things done. He was able to bring on thought leaders, credentialed professionals and still obtain non-dilutive financing. However, that's not all. Then, he shrewdly pitted the US FDA against 4 other countries, in an International game of chess, with a little game of chicken thrown in; just to see who flinched first. He continues to play that game. And, look! The FDA decided it wanted the data as soon as it was locked down, NOT weeks later after the Company had a chance to clean it and present it in the most pristine way. And, why? Because, IT WORKS!!! And, NP had the vision to see how it would work, back when he first took it off the shelf and blew the cobwebs off of it. After everyone told him no, NP persevered. It's BECAUSE OF NP, not in spite of him, that we are on the cusp of great things and great wealth!!!
Oh sure, those shareholders with the 8-figure share count...they were looking to sell cheap. It is of my opinion that they lack vision, conviction and courage and would have hurt the rest of the shareholders' dreams of achieving great wealth, because of their incessant complaints of NP. It is of my opinion, that these large shareholders need to shut their yaps. Because, if I didn't know any better, it would almost seem as if THEY were responsible for pumping figstain full of their own emotional hostility in an effort to have NP replaced. After all, figstain had lost his financial backing, and yet he continues to hold these hostile feelings towards NP. Ask yourself, 'why, would a self-proclaimed journalist continue to bring emotion-based arguments against the CEO, when the large short funds have already decided to go Long CYDY?' Could it be that there are others who are buttering his toast??
Chew on THAT for awhile!!
Recent CYDY News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/30/2024 09:01:16 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/07/2024 12:44:56 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/07/2024 12:42:22 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2024 09:21:30 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM